The objective of this Registry is to collect short and long-term post-transplant clinical outcome data of all donor lungs preserved and assessed on the OCS Lung System and to document the performance of the OCS device in the real-world setting after FDA approval in the US.
Study Type
OBSERVATIONAL
Enrollment
10,000
The TransMedics Organ Care System (OCS) Lung is an FDA approved portable extracorporeal lung perfusion and monitoring system.
St. Joseph's Hospital & Medical Center
Phoenix, Arizona, United States
RECRUITINGStanford University School of Medicine
Stanford, California, United States
RECRUITINGUniversity of Minnesota
Minneapolis, Minnesota, United States
One-year patient and graft survival
Recipients' one-year patient and graft survival rates
Time frame: 1-year post-transplant
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Duke University
Durham, North Carolina, United States
RECRUITINGBaylor Scott & White Research Institute
Dallas, Texas, United States
RECRUITINGBaylor College of Medicine
Houston, Texas, United States
RECRUITINGMedical College of Wisconsin
Milwaukee, Wisconsin, United States
RECRUITING